Avinger, Inc. (AVGR): Price and Financial Metrics


Avinger, Inc. (AVGR): $0.86

0.01 (+1.75%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

AVGR POWR Grades


  • Sentiment is the dimension where AVGR ranks best; there it ranks ahead of 97.37% of US stocks.
  • AVGR's strongest trending metric is Quality; it's been moving up over the last 35 weeks.
  • AVGR's current lowest rank is in the Stability metric (where it is better than 11.84% of US stocks).

AVGR Stock Summary

  • AVGR has a market capitalization of $81,050,052 -- more than approximately only 9.74% of US stocks.
  • The volatility of Avinger Inc's share price is greater than that of 93.99% US stocks with at least 200 days of trading history.
  • Shareholder yield, a measure of how much is returned to shareholders via dividends and share repurchases, for AVGR comes in at -30.95% -- higher than that of just 8.77% of stocks in our set.
  • Stocks that are quantitatively similar to AVGR, based on their financial statements, market capitalization, and price volatility, are PROG, ICAD, IRBT, AGE, and BCOV.
  • Visit AVGR's SEC page to see the company's official filings. To visit the company's web site, go to www.avinger.com.

AVGR Valuation Summary

  • In comparison to the median Healthcare stock, AVGR's EV/EBIT ratio is 116.04% lower, now standing at -4.7.
  • Over the past 80 months, AVGR's price/sales ratio has gone down 3.7.
  • AVGR's EV/EBIT ratio has moved up 1.2 over the prior 80 months.

Below are key valuation metrics over time for AVGR.

Stock Date P/S P/B P/E EV/EBIT
AVGR 2021-08-31 8.2 4.9 -4.1 -4.7
AVGR 2021-08-30 8.2 4.9 -4.1 -4.7
AVGR 2021-08-27 8.1 4.9 -4.1 -4.6
AVGR 2021-08-26 7.7 4.6 -3.9 -4.3
AVGR 2021-08-25 7.9 4.8 -4.0 -4.5
AVGR 2021-08-24 7.6 4.6 -3.8 -4.3

AVGR Growth Metrics

  • The 5 year cash and equivalents growth rate now stands at -82%.
  • Its 5 year net income to common stockholders growth rate is now at 46.18%.
  • Its 5 year price growth rate is now at -99.99%.
AVGR's revenue has moved up $1,264,000 over the prior 18 months.

The table below shows AVGR's growth in key financial areas (numbers in millions of US dollars).

Date Revenue Operating Cash Flow Net Income to Common Stock
2021-06-30 10.395 -14.984 -20.679
2021-03-31 9.059 -14.668 -22.15
2020-12-31 8.761 -14.835 -22.872
2020-09-30 8.591 -15.198 -23.293
2020-06-30 8.699 -16.044 -23.319
2020-03-31 9.552 -16.238 -23.898

AVGR's Quality Factors

The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.
  • AVGR has a Quality Grade of D, ranking ahead of 18.95% of graded US stocks.
  • AVGR's asset turnover comes in at 0.276 -- ranking 137th of 182 Medical Equipment stocks.
  • DXCM, HOLX, and ICAD are the stocks whose asset turnover ratios are most correlated with AVGR.

The table below shows AVGR's key quality metrics over time.

Period Asset Turnover Gross Margin ROIC
2021-06-30 0.276 0.353 -1.054
2021-03-31 0.257 0.332 -1.360
2020-12-31 0.288 0.299 -1.795
2020-09-30 0.306 0.298 -2.297
2020-06-30 0.336 0.303 -2.235
2020-03-31 0.369 0.314 -1.990

AVGR Price Target

For more insight on analysts targets of AVGR, see our AVGR price target page. And for a list of of all stocks sorted by upside potential based on analyst target price, see our Top Price Target page.

Average Price Target $2.50 Average Broker Recommendation 1.75 (Moderate Buy)

AVGR Stock Price Chart Interactive Chart >

Price chart for AVGR

AVGR Price/Volume Stats

Current price $0.86 52-week high $2.67
Prev. close $0.85 52-week low $0.21
Day low $0.82 Volume 562,100
Day high $0.86 Avg. volume 8,495,408
50-day MA $0.92 Dividend yield N/A
200-day MA $1.15 Market Cap 82.44M

Avinger, Inc. (AVGR) Company Bio


Avinger, Inc. designs, manufactures, and sells image-guided and catheter-based systems used by physicians to treat patients with peripheral arterial disease in the United States and Europe. The company was founded in 2007 and is based in Redwood City, California.


AVGR Latest News Stream


Event/Time News Detail
Loading, please wait...

AVGR Latest Social Stream


Loading social stream, please wait...

View Full AVGR Social Stream

Latest AVGR News From Around the Web

Below are the latest news stories about Avinger Inc that investors may wish to consider to help them evaluate AVGR as an investment opportunity.

Avinger, Inc.: Avinger To Present at the H.C. Wainwright 23rd Annual Global Investment Conference September 13-15

REDWOOD CITY, CA / ACCESSWIRE / September 8, 2021 / Avinger, Inc. (NASDAQ:AVGR), a commercial-stage medical device company marketing the first and only intravascular image-guided, catheter-based sy

FinanzNachrichten | September 8, 2021

Avinger To Present at the H.C. Wainwright 23rd Annual Global Investment Conference September 13-15

REDWOOD CITY, CA / ACCESSWIRE / September 8, 2021 / Avinger, Inc. (NASDAQ:AVGR), a commercial-stage medical device company marketing the first and only intravascular image-guided, catheter-based system for diagnosis and treatment of Peripheral Artery Disease (PAD), today announced that its management will participate in investor meetings September 13-15, 2021 as part of the H.

Yahoo | September 8, 2021

Does Avinger (NASDAQ:AVGR) Have A Healthy Balance Sheet?

David Iben put it well when he said, 'Volatility is not a risk we care about. What we care about is avoiding the...

Yahoo | September 3, 2021

Occlusion Removal Devices Market 2021, Know which is the Fast-Growing Segment Globally, Key Players -Boston Scientific (US),Avinger (US)

New York, United States :Our experts in the field of research at Decisive Markets Insights have effectively designed a report in the Occlusion Removal Devices MARKET market that covers all the underlying opportunities of market growth over the anticipated duration

OpenPR | August 25, 2021

Avinger OCT-Guided Technologies Featured at AMP 2021

REDWOOD CITY, CA / ACCESSWIRE / August 16, 2021 / Avinger, Inc. (NASDAQ:AVGR), a commercial-stage medical device company marketing the first and only intravascular image-guided, catheter-based system for diagnosis and treatment of Peripheral Artery Disease (PAD), today announced presentations featuring the Company's Lumivascular, OCT-guided, technologies at the annual AMP (Amputation Prevention Symposium) conference occurring last week.

Yahoo | August 16, 2021

Read More 'AVGR' Stories Here

AVGR Price Returns

1-mo 7.47%
3-mo -18.87%
6-mo -45.57%
1-year 146.00%
3-year -93.86%
5-year -99.95%
YTD 95.41%
2020 -61.39%
2019 -62.00%
2018 -95.83%
2017 -95.14%
2016 -83.71%

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!


Page generated in 0.7989 seconds.